Establishing the optimal dose of nitric oxide in acute vasoreactivity testing in patients with pulmonary hypertension with use of the Bronchial Control Treatment System (RCD code: II)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2015, Vol 2, Issue 4
Abstract
The key point in the diagnostic algorithm for pulmonary hypertension plays the pulmonary reactivity testing, the agent most frequently used in the test is inhaled nitric oxide (iNO). Various dosages of iNO were used in acute vasoreactivity testing so far, so we aimed to determine the most effective dose of iNO administered in the acute vasoreactivity testing. Ten consecutive patients was enrolled to the open label study. To assess the most effective dose of iNO increasing concentrations of iNO: 10 ppm, 20 ppm and 30 ppm were administered. In the study statistically significant reduction in mean pulmonary artery pressure after each dose of iNO as compared to baseline was found. There were no significant differences in mean pulmonary artery pressure between subsequent iNO doses (10 ppm vs. 20 ppm, 20 ppm vs. 30 ppm). Statistically significant reduction of systolic pulmonary artery pressure after iNO at the dose of 20 ppm as compared to a dose of 10 ppm was observed. No significant side effects during iNO administration were observed. We concluded that the dose of inhaled nitric oxide used in the acute vasoreactivity testing should not exceed 20 ppm, it is effective and safe dose.
Authors and Affiliations
Magdalena Kaznica-Wiatr, Maria Olszowska, Piotr Podolec
Keywords
Related Articles
- EP ID EP242019
- DOI 10.20418/jrcd.vol2no4.189
- Views 130
- Downloads 0
Giant cell aortitis of the ascending aorta without signs and symptoms of systemic vasculitis
We report a case of a patient with giant cell aortitis – a rare cause of aneurysm of the ascending aorta. Modern imaging techniques show promise in diagnosis, however the diagnosis only after hystopathotological examinat...
Large mediastinal teratoma causing recurrent pericarditis (RCD code: VI)
The mediastinal tumors are rare but potentially fatal diseases. Teratomas are derived from multipotent germ-line cells. In majority of cases mediastinal tumours are incidentally detected on chest X ray. We present 19-yea...
The atrial septal defect diagnosed in the senility – the benefit of the transcatheter closure (RCD code: IV‑2B.1)
Objective: Closure of the atrial septal defect in the elderly patients is controversial. The aim of the study was to evaluate the outcomes of transcatheter closure of secundum atrial septal defect (ASD) in elderly patien...
Left atrial myxoma as a cause of multiple cerebral microembolization (RCD code: VI‐1A.1)
We report a case of a 56-year-old female after breast cancer treatment, who was diagnosed with left atrial myxoma as a rare cause of cerebral and cerebellar stroke.JRCD 2017; 3 (5): 168–170
Wunderlich’s syndrome associated with anticoa gulant treatment, heart failure, and post‐radiation vasculopathy
Background: Wunderlich’s syndrome (WS) is an extremely rare condition, characterised by spontaneous haemorrhage into the subcapsular, perirenal, and retroperitoneal spaces. The most common cause is renal angiomyolipoma....